Zobrazeno 1 - 10
of 105
pro vyhledávání: '"J A, Plumb"'
Publikováno v:
Cancer Nanotechnology
The present study was designed to explore the ability of polymeric nanoparticles to restore drug sensitivity to P-glycoprotein over-expressing cancer cells. A multidrug-resistant cell line 2780 AD and its sensitive parent cell line A2780 were studied
Publikováno v:
Letters in Applied Microbiology. 29:71-75
Strains of bacteria were obtained by anaerobic enrichment from feedlot manure pads and were phenotypically characterized. Colonies had a cotton wool or hairy appearance. When cultures grown in liquid media were exposed to a drying atmosphere, they pr
Publikováno v:
Experimental Physiology. 84:285-297
Publikováno v:
Experimental Physiology. 84:285-297
Experiments were undertaken using an ovarian adenocarcinoma cell line (A2780) and a drug-resistant strain (A2780. ad ) derived from this line. P-glycoprotein could not be detected in A2780 cells but was essentially ubiquitous in A2780 .ad cells, alth
Publikováno v:
Letters in Applied Microbiology. 23:13-17
A polymerase chain reaction (PCR) was used to identify the gene-encoding epsilon toxin production in Clostridium perfringens types B and D in faeces and in gastrointestinal contents of goats. The samples were cultured in thioglycollate broth and cent
Publikováno v:
Diseases of Aquatic Organisms. 27:19-24
Autor:
J A, Plumb
Publikováno v:
Methods in molecular medicine. 28
The clonogenic assay described in Chapter 2 is not suitable for all cell lines. Many adherent cell lines do not form colonies and clearly it is not applicable to non-adherent cell lines. Furthermore, it is slow and time consuming. This chapter descri
Autor:
J A, Plumb
Publikováno v:
Methods in molecular medicine. 28
The use of cell culture systems to assess the toxicity of anticancer agents began over 50 years ago following the observation of the antineoplastic effects of nitrogen mustard (1). There are a wide variety of assays designed to evaluate cellular drug
Publikováno v:
International journal of laboratory hematology. 32(4)
Next-generation oral anticoagulants offer the potential for effective prevention and treatment of thrombosis without the need for repeated monitoring of the international normalized ratio (INR). This systematic review evaluated the costs associated w